Trulieve Cannabis Corp. quarterly report, Q3 FY2023

Trulieve Cannabis Corp. — Q3 2023 Form 10-Q

Reporting period: Quarter and nine months ended September 30, 2023. Unaudited results are compared with the corresponding 2022 periods. Unless otherwise noted, amounts are U.S. dollars.

Business context

Trulieve is a vertically integrated, multi-state cannabis operator. At quarter-end it operated 188 dispensaries and 17 cultivation and processing facilities. Florida is its cornerstone market. In June 2023, the company approved an exit from Massachusetts; those results are reported as discontinued operations. It also continued to shed certain underperforming assets.

Financial performance

MetricQ3 2023Q3 2022Nine months 2023Nine months 2022
Revenue$275.2 million$295.4 million$842.2 million$919.8 million
Gross profit / margin$142.9 million / 51.9%$168.7 million / 57.1%$434.8 million / 51.6%$532.0 million / 57.8%
Operating income (loss)$23.3 million$(27.3) million$(250.8) million$45.0 million
Net loss from continuing operations$(22.9) million$(72.6) million$(399.3) million$(118.4) million
Total net loss$(25.8) million$(115.1) million$(498.3) million$(171.6) million
Adjusted EBITDA (non-GAAP)$77.7 million$99.6 million$234.6 million$315.5 million

Q3 revenue declined 6.8% year over year, reflecting lower retail and wholesale sales amid increased competition and promotions, as well as the company’s decision to forgo some lower-margin wholesale business. Gross margin contracted as promotional activity, price compression, a shift toward value products, inventory reductions, and costs at temporarily idled facilities weighed on results. Q3 operating results improved from the prior year, which included substantial asset-exit costs; a gain on repurchasing debt also contributed. Adjusted EBITDA fell 22% in Q3 and 26% for the first nine months year over year.

The nine-month continuing-operations loss includes a $307.6 million non-cash goodwill impairment recorded in Q2. The company attributed it to lower cannabis-sector valuations and its reduced market capitalization, and said it did not affect cash flows, liquidity, or debt-covenant compliance. Discontinued operations recorded a $99.1 million loss for the first nine months, including costs associated with the Massachusetts exit.

Cash flow, balance sheet and debt

  • Nine-month operating cash flow was $70.4 million, versus cash used of $31.9 million in 2022. Management cited inventory reductions and lower tax payments. Investing cash use was $30.3 million, compared with $179.0 million; financing cash use was $60.6 million, versus $91.9 million provided in 2022. Cash, cash equivalents and restricted cash ended the period at $198.9 million.
  • Cash and cash equivalents were $192.2 million at September 30, down from $207.2 million at year-end 2022. Total assets were $2.78 billion and total liabilities $1.33 billion.
  • Private placement notes had $498 million principal outstanding; notes payable had $103.0 million gross carrying amount. The company repurchased $57 million principal of 2026 notes for about $48 million, recognizing an $8.2 million gain; it estimated approximately $14 million of interest savings over the remaining term. These borrowings are in addition to lease and construction-finance liabilities.
  • On November 8, 2023, the company announced redemption of $130 million of senior secured notes due in 2024, scheduled for December 1, 2023.
  • Management stated that existing cash was expected to cover anticipated requirements for at least 12 months from the filing date.

Outlook, risks and unusual items

  • No specific revenue, earnings, or operating guidance is provided. Management expects cost-streamlining and capacity initiatives to yield future savings and benefits, but those outcomes are uncertain.
  • The company disputes tax liabilities under Internal Revenue Code Section 280E. It recorded a $36.6 million Q3 tax provision despite $13.7 million of pretax income, and reported net uncertain tax liabilities of approximately $81.4 million, net of tax payments on deposit. Separately, it reported $470.5 million of gross unrecognized tax benefits and $116.6 million of tax payments on deposit. In October 2023 it filed refund claims totaling $143 million for 2019–2021; the claims may increase audit risk and are not assured of recovery.
  • Cannabis remains illegal under U.S. federal law, creating regulatory, enforcement, asset-forfeiture, banking, and tax risks. Competition and price compression are also pressuring sales and margins.
  • Management concluded disclosure controls were not effective at September 30 because material weaknesses remained in information technology and inventory valuation controls. It said the previously identified weakness concerning variable interest entities had been remediated. Management nevertheless concluded the reported financial statements fairly present the company’s financial position and results in all material respects.
  • The filing reports no pending or threatened litigation expected to materially affect results. It does describe lease guarantees and other commitments; total contractual obligations were reported at $1.32 billion, including obligations associated with discontinued operations.

Important facts for investors to verify

  • Whether revenue and gross-margin pressure persists, and whether cost reductions offset competition, promotions, and excess-capacity costs.
  • The timing, funding, and completion of the announced $130 million note redemption, alongside other debt maturities and covenant requirements.
  • The status and potential cash impact of the Section 280E refund claims, uncertain tax positions, and any resulting IRS audit.
  • Progress in remediating the remaining IT and inventory-control material weaknesses.
  • Execution and final costs of the Massachusetts exit and other asset dispositions, and whether management’s 12-month liquidity assessment remains supportable.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.